Chembio Diagnostics develops, manufactures, and markets proprietary diagnostic tests for the healthcare industry. The company’s rapid HIV testing product is known as the HIV STAT-PAK®, and is patented and fully approved by the FDA. The company recently reported record-breaking total revenues for the quarter ended June 30th, 2008.

This year’s second quarter led to the lowest losses for the company since 2004, as well as astonishingly high total revenue. In total, revenues for the quarter reached $2.72 million, increasing more than eight percent over the $2.5 million recorded in the first three months of 2008. Of the $2.72 million, $2.21 million came from the company’s rapid HIV testing products. Gross profit was also up significantly; climbing more than thirty percent to $1.3 million.

Lawrence Siebert, President and CEO, said, “We are pleased at the continued improvements from our base lateral flow business as we approach realizing new revenue streams from our products. We expect to continue this momentum despite a difficult economic environment as our products serve a global market.”

Let us hear your thoughts below:

Last 5 posts by QualityStocks

• Omnicity Corp. (OMCY.OB) Announces Addition of New Board Member - November 20th, 2009
• Muscle Flex, Inc. (MFLI.PK) Announces Release Time for the BUDDY Tablet Caddy Two-Minute Commercial and Landing Page - November 20th, 2009
• Artfest International, Inc. (ARTS.OB) Announces Revenue Profit Jumps - November 20th, 2009
• Omnicity Corp.’s (OMCY.OB) Recently-Issued Corporate Update - November 20th, 2009
• Soligenix Inc. (SNGX.OB) Taking Steps to Meet Challenges of Vaccine Technology and Biological Warfare - November 20th, 2009